Long-Term Safety Study of CTX0E03 in Subjects Who Completed PISCES III Study
- Conditions
- Ischemic Stroke
- First Posted Date
- 2022-10-28
- Last Posted Date
- 2023-03-31
- Lead Sponsor
- ReNeuron Limited
- Target Recruit Count
- 9
- Registration Number
- NCT05598775
- Locations
- ๐บ๐ธ
Amy Miller, RPh, PharmD, Morgantown, West Virginia, United States
Investigation of Neural Stem Cells in Ischemic Stroke
- Conditions
- Ischemic StrokeChronic StrokeHemiparesisArm Paralysis
- Interventions
- Combination Product: CTX0E03 Drug Product and delivery deviceDrug: Placebo
- First Posted Date
- 2018-08-14
- Last Posted Date
- 2021-08-13
- Lead Sponsor
- ReNeuron Limited
- Target Recruit Count
- 15
- Registration Number
- NCT03629275
- Locations
- ๐บ๐ธ
Augusta University, Augusta, Georgia, United States
๐บ๐ธUniversity of California, Irvine, Irvine, California, United States
๐บ๐ธEmory, Atlanta, Georgia, United States
An Ischaemic Stroke Observational Study
- Conditions
- Stroke
- First Posted Date
- 2017-11-07
- Last Posted Date
- 2017-12-05
- Lead Sponsor
- ReNeuron Limited
- Target Recruit Count
- 39
- Registration Number
- NCT03333980
- Locations
- ๐ฌ๐ง
Ninewells Hospital & Medical School, Dundee, United Kingdom
๐ฌ๐งNew Queen Elizabeth Hospital, Birmingham, United Kingdom
๐ฌ๐งQueen Elizabeth University Hospital., Glasgow, United Kingdom
Safety and Tolerability of hRPC in Retinitis Pigmentosa
- Conditions
- Retinitis Pigmentosa
- Interventions
- Drug: hRPC
- First Posted Date
- 2015-06-08
- Last Posted Date
- 2023-07-06
- Lead Sponsor
- ReNeuron Limited
- Target Recruit Count
- 29
- Registration Number
- NCT02464436
- Locations
- ๐บ๐ธ
Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
๐บ๐ธRetinal Research Institute, Phoenix, Arizona, United States
๐ช๐ธInstitut de la Mร cula, Barcelona, Spain
Pilot Investigation of Stem Cells in Stroke Phase II Efficacy
- Conditions
- HemiparesisIschaemic StrokeArm ParalysisCerebral Infarction
- Interventions
- Biological: CTX DP
- First Posted Date
- 2014-04-21
- Last Posted Date
- 2018-07-23
- Lead Sponsor
- ReNeuron Limited
- Target Recruit Count
- 23
- Registration Number
- NCT02117635
- Locations
- ๐ฌ๐ง
NHS Southern General Hospital, Glasgow, United Kingdom
๐ฌ๐งKings College Hospital, London, United Kingdom
๐ฌ๐งQueen Elizabeth Hospital, Birmingham, United Kingdom
Safety Trial Of CTX Cells In Patients With Lower Limb Ischaemia
- Conditions
- Peripheral Arterial Disease
- Interventions
- Biological: CTX DP
- First Posted Date
- 2013-08-05
- Last Posted Date
- 2018-01-31
- Lead Sponsor
- ReNeuron Limited
- Target Recruit Count
- 5
- Registration Number
- NCT01916369
- Locations
- ๐ฌ๐ง
Ninewells Hospital, Dundee, Scotland, United Kingdom
Observational Study of Ischaemic Stroke
- Conditions
- StrokeMotor Activity
- First Posted Date
- 2013-05-22
- Last Posted Date
- 2016-12-19
- Lead Sponsor
- ReNeuron Limited
- Target Recruit Count
- 110
- Registration Number
- NCT01859572
- Locations
- ๐ฌ๐ง
Glasgow Southern General Hospital, Glasgow, United Kingdom
Pilot Investigation of Stem Cells in Stroke
- Conditions
- Stroke
- Interventions
- Biological: CTX0E03 neural stem cells
- First Posted Date
- 2010-06-25
- Last Posted Date
- 2023-07-06
- Lead Sponsor
- ReNeuron Limited
- Target Recruit Count
- 11
- Registration Number
- NCT01151124
- Locations
- ๐ฌ๐ง
Division of Clinical Neurosciences, Glasgow Southern General Hospital, Glasgow, United Kingdom